Avalo Therapeutics, Inc. (AVTX)
NASDAQ·Healthcare·Biotechnology
$17.88
-0.89%
Mkt Cap $218.99M
Analyst Ratings
Buy
10
Hold
0
Sell
0
Price Target (11 analysts)
$47.14
Range $34.00 – $60.00
Implied Upside
+163.6%
Consensus $47.14 vs current $17.88
NASDAQ·Healthcare·Biotechnology
$17.88
-0.89%
Mkt Cap $218.99M
Buy
10
Hold
0
Sell
0
Price Target (11 analysts)
$47.14
Range $34.00 – $60.00
+163.6%
Consensus $47.14 vs current $17.88